Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement

por Gao, Qiongqiong, Li, Pupu, Jiang, Xiangli, Zhan, Zhongli, Yan, Qingna, Zhang, Bo, Huang, Chun
Publicado en Oncotarget (2017)

Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma

por Li, Pupu, Gao, Qiongqiong, Jiang, Xiangli, Zhan, Zhongli, Yan, Qingna, Li, Zhaona, Huang, Chun
Publicado en J Cancer (2019)

Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling

por Yue, Ying, Song, Mengjia, Qiao, Yamin, Li, Pupu, Yuan, Yiqiang, Lian, Jingyao, Wang, Suying, Zhang, Yi
Publicado en Oncotarget (2017)

Correction: Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling

por Yue, Ying, Song, Mengjia, Qiao, Yamin, Li, Pupu, Yuan, Yiqiang, Lian, Jingyao, Wang, Suying, Zhang, Yi
Publicado en Oncotarget (2020)

Sequential ALK inhibitor treatment benefits patient with leptomeningeal metastasis harboring non‐EML4‐ALK rearrangements detected from cerebrospinal fluid: A case report

por Li, Zhaona, Li, Pupu, Yan, Bing, Gao, Qiongqiong, Jiang, Xiangli, Zhan, Zhongli, Yan, Qingna, Lizaso, Analyn, Huang, Chun
Publicado en Thorac Cancer (2019)